Correlation Engine 2.0
Clear Search sequence regions


  • antibodies (2)
  • bacterin (4)
  • interferon γ (1)
  • korean (3)
  • lung lesions (1)
  • mycoplasma (3)
  • pneumonia (1)
  • strain (1)
  • swine (2)
  • vaccines (2)
  • Sizes of these terms reflect their relevance to your search.

    The objective of this study was to evaluate the efficacy of a new Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge under experimental conditions. Fifteen pigs were allocated randomly into 3 groups (5 pigs per group) that were designated in 1 of 3 ways: vaccinated-challenged, unvaccinated-challenged, or unvaccinated-unchallenged. The pigs in the vaccinated-challenged group were immunized with an M. hyopneumoniae whole-cell bacterin at a 1.0 mL dose-level at 21 d old. At 42 d old (0 d post-challenge), the pigs in the vaccinated-challenged and unvaccinated-challenged groups were inoculated intranasally with a strain of Korean M. hyopneumoniae. Vaccinated-challenged pigs elicited a strong cell-mediated immunity as measured by M. hyopneumoniae-specific interferon-γ secreting cells when compared with unvaccinated-challenged pigs. Vaccination of pigs with this new M. hyopneumoniae bacterin reduced nasal shedding and lung lesions. The evaluated vaccine was therefore considered effective in controlling M. hyopneumoniae infection. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

    Citation

    SooHwan Kim, Taehwan Oh, Siyeon Yang, Hyejean Cho, Chanhee Chae. Experimental evaluation of Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire. 2021 Jan;85(1):77-81

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33390658

    View Full Text